ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia.

Ivana Gojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.